Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 519

1.

EVOLUTIONARY DISTANCE PREDICTS RECURRENCE AFTER LIVER TRANSPLANTATION IN MULTIFOCAL HEPATOCELLULAR CARCINOMA.

Heits N, Brosch M, Herrmann A, Behrens R, Röcken C, Schrem H, Kaltenborn A, Klempnauer J, Kreipe HH, Reichert B, Lenschow C, Wilms C, Vogel T, Wolters H, Wardelmann E, Seehofer D, Buch S, Zeissig S, Pannach S, Raschzok N, Dietel M, von Schoenfels W, Hinz S, Teufel A, Evert M, Franke A, Becker T, Braun F, Hampe J, Schafmayer C.

Transplantation. 2018 Jul 9. doi: 10.1097/TP.0000000000002356. [Epub ahead of print]

PMID:
29994984
2.

Coincidence of lymphomatoid granulomatosis, chronic myelomonocytic leukemia, and anaplastic T cell lymphoma after methotrexate therapy for rheumatoid arthritis.

Dugge R, Kreipe H, Rosenwald A, Lehmann U, Möller P, Barth TFE, Erlemann R.

Ann Hematol. 2018 Jul 7. doi: 10.1007/s00277-018-3434-2. [Epub ahead of print] No abstract available.

PMID:
29982850
3.

Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis.

Hussein K, Stucki-Koch A, Kreipe H.

Ann Hematol. 2018 Jun 30. doi: 10.1007/s00277-018-3411-9. [Epub ahead of print]

PMID:
29961094
4.

Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial.

Suttorp M, Schulze P, Glauche I, Göhring G, von Neuhoff N, Metzler M, Sedlacek P, de Bont ESJM, Balduzzi A, Lausen B, Aleinikova O, Sufliarska S, Henze G, Strauss G, Eggert A, Kremens B, Groll AH, Berthold F, Klein C, Groß-Wieltsch U, Sykora KW, Borkhardt A, Kulozik AE, Schrappe M, Nowasz C, Krumbholz M, Tauer JT, Claviez A, Harbott J, Kreipe HH, Schlegelberger B, Thiede C.

Leukemia. 2018 Jun 20. doi: 10.1038/s41375-018-0179-9. [Epub ahead of print]

PMID:
29925908
5.

Non-canonical WNT6/WNT10A signal factor expression in EBV+ post-transplant smooth muscle tumors.

Teiken K, Kuehnel M, Rehkaemper J, Kreipe H, Laenger F, Hussein K, Jonigk D.

Clin Sarcoma Res. 2018 Jun 4;8:10. doi: 10.1186/s13569-018-0096-8. eCollection 2018.

6.

[Possibilities and limitations of molecular pathology in dermatohistology].

Schacht V, Lehmann U, Reineke-Plaass T, Länger F, Auber B, Morlot S, Kreipe HH.

Hautarzt. 2018 Jun 6. doi: 10.1007/s00105-018-4206-6. [Epub ahead of print] Review. German.

PMID:
29876610
7.

Hotspot mutations in cancer genes may be missed in routine diagnostics due to neighbouring sequence variants.

Bartels S, Schipper E, Hasemeier B, Kreipe H, Lehmann U.

Exp Mol Pathol. 2018 May 27;105(1):37-40. doi: 10.1016/j.yexmp.2018.05.010. [Epub ahead of print]

PMID:
29847769
8.

CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer.

Bartels S, van Luttikhuizen JL, Christgen M, Mägel L, Luft A, Hänzelmann S, Lehmann U, Schlegelberger B, Leo F, Steinemann D, Kreipe H.

J Pathol. 2018 Jul;245(3):373-383. doi: 10.1002/path.5091. Epub 2018 May 28.

PMID:
29708279
9.

Molecular profile of inflammatory and megakaryocytic factors in pediatric myelodysplastic syndrome with acute myelofibrosis.

Hussein K, Suttorp M, Stucki-Koch A, Baumann I, Niemeyer CM, Kreipe H.

Pediatr Blood Cancer. 2018 Jul;65(7):e27048. doi: 10.1002/pbc.27048. Epub 2018 Apr 18.

PMID:
29667765
10.

Molecular defects in BRAF wild-type ameloblastomas and craniopharyngiomas-differences in mutation profiles in epithelial-derived oropharyngeal neoplasms.

Bartels S, Adisa A, Aladelusi T, Lemound J, Stucki-Koch A, Hussein S, Kreipe H, Hartmann C, Lehmann U, Hussein K.

Virchows Arch. 2018 Jun;472(6):1055-1059. doi: 10.1007/s00428-018-2323-3. Epub 2018 Mar 15.

PMID:
29546640
11.

[Clinical and pathological characteristics of intravascular lymphomas].

Abraham L, Kreipe H, Raab P, Hussein K.

Pathologe. 2018 May;39(3):242-248. doi: 10.1007/s00292-018-0427-9. Review. German.

PMID:
29541829
12.

Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab.

Satzger I, Ivanyi P, Länger F, Kreipe HH, Schaper-Gerhardt K, Beutel G, Cornberg M, Gutzmer R.

Eur J Cancer. 2018 Apr;93:150-153. doi: 10.1016/j.ejca.2018.01.063. Epub 2018 Feb 19. No abstract available.

PMID:
29472154
13.

Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.

Gluz O, Nitz U, Liedtke C, Christgen M, Grischke EM, Forstbauer H, Braun M, Warm M, Hackmann J, Uleer C, Aktas B, Schumacher C, Bangemann N, Lindner C, Kuemmel S, Clemens M, Potenberg J, Staib P, Kohls A, von Schumann R, Kates R, Kates R, Schumacher J, Wuerstlein R, Kreipe HH, Harbeck N.

J Natl Cancer Inst. 2018 Jun 1;110(6):628-637. doi: 10.1093/jnci/djx258.

PMID:
29228315
14.

Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal.

Valent P, Akin C, Arock M, Bock C, George TI, Galli SJ, Gotlib J, Haferlach T, Hoermann G, Hermine O, Jäger U, Kenner L, Kreipe H, Majeti R, Metcalfe DD, Orfao A, Reiter A, Sperr WR, Staber PB, Sotlar K, Schiffer C, Superti-Furga G, Horny HP.

EBioMedicine. 2017 Dec;26:17-24. doi: 10.1016/j.ebiom.2017.11.024. Epub 2017 Nov 26. Review.

15.

EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC - Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®).

Petersen I, Dietel M, Geilenkeuser WJ, Mireskandari M, Weichert W, Steiger K, Scheel AH, Büttner R, Schirmacher P, Warth A, Lasitschka F, Schildhaus HU, Kirchner T, Reu S, Kreipe H, Länger F, Tiemann M, Schulte C, Jöhrens K.

Pathol Res Pract. 2017 Dec;213(12):1530-1535. doi: 10.1016/j.prp.2017.09.021. Epub 2017 Sep 28.

16.

18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.

Derlin T, Braubach P, Kreipe HH, Hueper K.

Clin Nucl Med. 2017 Dec;42(12):988-989. doi: 10.1097/RLU.0000000000001876.

PMID:
29076909
17.

Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.

Raap M, Gronewold M, Christgen H, Glage S, Bentires-Alj M, Koren S, Derksen PW, Boelens M, Jonkers J, Lehmann U, Feuerhake F, Kuehnle E, Gluz O, Kates R, Nitz U, Harbeck N, Kreipe HH, Christgen M.

Lab Invest. 2018 Jan;98(1):117-129. doi: 10.1038/labinvest.2017.106. Epub 2017 Oct 16.

PMID:
29035379
18.

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel.

Nitz UA, Gluz O, Christgen M, Grischke EM, Augustin D, Kuemmel S, Braun M, Potenberg J, Kohls A, Krauss K, Stefek A, Schumacher C, Forstbauer H, Reimer T, Fischer H, Liedtke C, Wuerstlein R, Schumacher J, Kates R, Kreipe H, Harbeck N; West-German Study Group (WSG)-ADAPT Investigators.

Ann Oncol. 2017 Nov 1;28(11):2768-2772. doi: 10.1093/annonc/mdx494.

PMID:
28945833
19.

Fibrotic progression in Polycythemia vera is associated with early concomitant driver-mutations besides JAK2.

Bartels S, Faisal M, Büsche G, Schlue J, Kreipe H, Lehmann U.

Leukemia. 2018 Feb;32(2):556-558. doi: 10.1038/leu.2017.298. Epub 2017 Sep 22. No abstract available.

PMID:
28935989
20.

EGFR T790M mutation testing of non-small cell lung cancer tissue and blood samples artificially spiked with circulating cell-free tumor DNA: results of a round robin trial.

Fassunke J, Ihle MA, Lenze D, Lehmann A, Hummel M, Vollbrecht C, Penzel R, Volckmar AL, Stenzinger A, Endris V, Jung A, Lehmann U, Zeugner S, Baretton G, Kreipe H, Schirmacher P, Kirchner T, Dietel M, Büttner R, Merkelbach-Bruse S.

Virchows Arch. 2017 Oct;471(4):509-520. doi: 10.1007/s00428-017-2226-8. Epub 2017 Sep 8.

PMID:
28884371
21.

Estrogen receptor (ESR1) mutation in bone metastases from breast cancer.

Bartels S, Christgen M, Luft A, Persing S, Jödecke K, Lehmann U, Kreipe H.

Mod Pathol. 2018 Jan;31(1):56-61. doi: 10.1038/modpathol.2017.95. Epub 2017 Aug 11.

PMID:
28799536
22.

Subclonal analysis in a lobular breast cancer with classical and solid growth pattern mimicking a solid-papillary carcinoma.

Christgen M, Bartels S, van Luttikhuizen JL, Schieck M, Pertschy S, Kundu S, Lehmann U, Sander B, Pelz E, Länger F, Schlegelberger B, Steinemann D, Kreipe H.

J Pathol Clin Res. 2017 Jul 19;3(3):191-202. doi: 10.1002/cjp2.76. eCollection 2017 Jul.

23.

Molecular Analysis of Circulating Cell-Free DNA from Lung Cancer Patients in Routine Laboratory Practice: A Cross-Platform Comparison of Three Different Molecular Methods for Mutation Detection.

Bartels S, Persing S, Hasemeier B, Schipper E, Kreipe H, Lehmann U.

J Mol Diagn. 2017 Sep;19(5):722-732. doi: 10.1016/j.jmoldx.2017.05.008. Epub 2017 Jul 16.

PMID:
28723342
24.

Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.

Thomay K, Fedder C, Hofmann W, Kreipe H, Stadler M, Titgemeyer J, Zander I, Schlegelberger B, Göhring G.

Ann Hematol. 2017 Sep;96(9):1493-1500. doi: 10.1007/s00277-017-3055-1. Epub 2017 Jul 9.

PMID:
28691153
25.

Fluorescence In Situ Hybridization for Diagnosis of Whipple's Disease in Formalin-Fixed Paraffin-Embedded Tissue.

Braubach P, Lippmann T, Raoult D, Lagier JC, Anagnostopoulos I, Zender S, Länger FP, Kreipe HH, Kühnel MP, Jonigk D.

Front Med (Lausanne). 2017 Jun 22;4:87. doi: 10.3389/fmed.2017.00087. eCollection 2017.

26.

De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.

Harbeck N, Gluz O, Christgen M, Kates RE, Braun M, Küemmel S, Schumacher C, Potenberg J, Kraemer S, Kleine-Tebbe A, Augustin D, Aktas B, Forstbauer H, Tio J, von Schumann R, Liedtke C, Grischke EM, Schumacher J, Wuerstlein R, Kreipe HH, Nitz UA.

J Clin Oncol. 2017 Sep 10;35(26):3046-3054. doi: 10.1200/JCO.2016.71.9815. Epub 2017 Jul 6.

PMID:
28682681
27.

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.

Nitz U, Gluz O, Christgen M, Kates RE, Clemens M, Malter W, Nuding B, Aktas B, Kuemmel S, Reimer T, Stefek A, Lorenz-Salehi F, Krabisch P, Just M, Augustin D, Liedtke C, Chao C, Shak S, Wuerstlein R, Kreipe HH, Harbeck N.

Breast Cancer Res Treat. 2017 Oct;165(3):573-583. doi: 10.1007/s10549-017-4358-6. Epub 2017 Jun 29.

PMID:
28664507
28.

Variant of classical high grade PTLD: post-transplant EBV-negative T cell lymphoblastic leukaemia after solid organ transplantation.

Teiken K, Kreipe H, Maecker-Kolhoff B, Hussein K.

Ann Hematol. 2017 Aug;96(8):1403-1405. doi: 10.1007/s00277-017-3026-6. Epub 2017 Jun 14. No abstract available.

PMID:
28616657
29.

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.

Heuser M, Gabdoulline R, Löffeld P, Dobbernack V, Kreimeyer H, Pankratz M, Flintrop M, Liebich A, Klesse S, Panagiota V, Stadler M, Wichmann M, Shahswar R, Platzbecker U, Thiede C, Schroeder T, Kobbe G, Geffers R, Schlegelberger B, Göhring G, Kreipe HH, Germing U, Ganser A, Kröger N, Koenecke C, Thol F.

Ann Hematol. 2017 Aug;96(8):1361-1372. doi: 10.1007/s00277-017-3027-5. Epub 2017 Jun 13.

PMID:
28612220
30.

[Analysis of therapy-relevant receptors in bone marrow carcinosis : Comparison of pathological and clinical parameters].

Massenkeil G, Gropp C, Kreipe H, Hussein K.

Pathologe. 2017 Jul;38(4):317-323. doi: 10.1007/s00292-017-0300-2. German.

PMID:
28577052
31.

Quality assurance trials for Ki67 assessment in pathology.

Raap M, Ließem S, Rüschoff J, Fisseler-Eckhoff A, Reiner A, Dirnhofer S, von Wasielewski R, Kreipe H.

Virchows Arch. 2017 Oct;471(4):501-508. doi: 10.1007/s00428-017-2142-y. Epub 2017 May 11.

PMID:
28497316
32.

Image analysis of immune cell patterns in the human mammary gland during the menstrual cycle refines lymphocytic lobulitis.

Schaadt NS, Alfonso JCL, Schönmeyer R, Grote A, Forestier G, Wemmert C, Krönke N, Stoeckelhuber M, Kreipe HH, Hatzikirou H, Feuerhake F.

Breast Cancer Res Treat. 2017 Jul;164(2):305-315. doi: 10.1007/s10549-017-4239-z. Epub 2017 Apr 25.

PMID:
28444535
33.

[University Pathology in Germany].

Röcken C, Baretton GB, Kreipe HH, Kirchner T.

Pathologe. 2017 Jul;38(4):324-330. doi: 10.1007/s00292-017-0285-x. German. No abstract available.

PMID:
28432389
34.

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.

Kröger N, Panagiota V, Badbaran A, Zabelina T, Triviai I, Araujo Cruz MM, Shahswar R, Ayuk F, Gehlhaar M, Wolschke C, Bollin R, Walter C, Dugas M, Wiehlmann L, Lehmann U, Koenecke C, Chaturvedi A, Alchalby H, Stadler M, Eder M, Christopeit M, Göhring G, Koenigsmann M, Schlegelberger B, Kreipe HH, Ganser A, Stocking C, Fehse B, Thol F, Heuser M.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1095-1101. doi: 10.1016/j.bbmt.2017.03.034. Epub 2017 Apr 4.

35.

Macrophage density in early surveillance biopsies predicts future renal transplant function.

Bräsen JH, Khalifa A, Schmitz J, Dai W, Einecke G, Schwarz A, Hallensleben M, Schmidt BMW, Kreipe HH, Haller H, von Vietinghoff S.

Kidney Int. 2017 Aug;92(2):479-489. doi: 10.1016/j.kint.2017.01.029. Epub 2017 Mar 27.

PMID:
28359537
36.

[Colorectal cancer and associated sebaceous gland carcinoma - a syndrome?]

Harms J, Kunzmann B, Reineke-Plaass T, Kreipe HH, Reinecke-Lüthge A, Czymek R, Jungbluth T.

Chirurg. 2017 Aug;88(8):699-701. doi: 10.1007/s00104-017-0408-1. German. No abstract available.

PMID:
28321454
37.

hsa-mir-183 is frequently methylated and related to poor survival in human hepatocellular carcinoma.

Anwar SL, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Buurman R, Skawran B, Lehmann U.

World J Gastroenterol. 2017 Mar 7;23(9):1568-1575. doi: 10.3748/wjg.v23.i9.1568.

38.

HER2 testing in gastric cancer: results of a German expert meeting.

Lordick F, Al-Batran SE, Dietel M, Gaiser T, Hofheinz RD, Kirchner T, Kreipe HH, Lorenzen S, Möhler M, Quaas A, Röcken C, Rüschoff J, Tannapfel A, Thuss-Patience P, Baretton G.

J Cancer Res Clin Oncol. 2017 May;143(5):835-841. doi: 10.1007/s00432-017-2374-x. Epub 2017 Mar 11. Review.

39.

Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis.

Hussein K, Stucki-Koch A, Göhring G, Kreipe H, Suttorp M.

Leukemia. 2017 Jul;31(7):1540-1546. doi: 10.1038/leu.2017.73. Epub 2017 Feb 27.

PMID:
28239144
40.

Comparative analysis of morphological and molecular motifs in bronchiolitis obliterans and alveolar fibroelastosis after lung and stem cell transplantation.

Jonigk D, Rath B, Borchert P, Braubach P, Maegel L, Izykowski N, Warnecke G, Sommer W, Kreipe H, Blach R, Anklamm A, Haverich A, Eder M, Stadler M, Welte T, Gottlieb J, Kuehnel M, Laenger F.

J Pathol Clin Res. 2016 Dec 10;3(1):17-28. doi: 10.1002/cjp2.60. eCollection 2017 Jan.

41.

PSMA Expression in Tumor Neovasculature Endothelial Cells of Follicular Thyroid Adenoma as Identified by Molecular Imaging Using 68Ga-PSMA Ligand PET/CT.

Derlin T, Kreipe HH, Schumacher U, Soudah B.

Clin Nucl Med. 2017 Mar;42(3):e173-e174. doi: 10.1097/RLU.0000000000001487.

PMID:
27997422
42.

The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.

Weissinger EM, Human C, Metzger J, Hambach L, Wolf D, Greinix HT, Dickinson AM, Mullen W, Jonigk D, Kuzmina Z, Kreipe H, Schweier P, Böhm O, Türüchanow I, Ihlenburg-Schwarz D, Raad J, Durban A, Schiemann M, Könecke C, Diedrich H, Holler E, Beutel G, Krauter J, Ganser A, Stadler M.

Leukemia. 2017 Mar;31(3):654-662. doi: 10.1038/leu.2016.259. Epub 2016 Sep 28.

PMID:
27677743
43.

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.

Schlenk RF, Stegelmann F, Reiter A, Jost E, Gattermann N, Hebart H, Waller C, Hochhaus A, Platzbecker U, Schafhausen P, Blau IW, Verbeek W, Heidel FH, Werner M, Kreipe H, Teleanu V, Benner A, Döhner H, Grießhammer M, Döhner K.

Leukemia. 2017 Apr;31(4):889-895. doi: 10.1038/leu.2016.299. Epub 2016 Oct 24.

PMID:
27774990
44.

Assessing HER2 testing quality in breast cancer: variables that influence HER2 positivity rate from a large, multicenter, observational study in Germany.

Rüschoff J, Lebeau A, Kreipe H, Sinn P, Gerharz CD, Koch W, Morris S, Ammann J, Untch M; Nicht-interventionelle Untersuchung (NIU) HER2 Study Group.

Mod Pathol. 2017 Feb;30(2):217-226. doi: 10.1038/modpathol.2016.164. Epub 2016 Oct 21.

45.

Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.

Christgen M, van Luttikhuizen JL, Raap M, Braubach P, Schmidt L, Jonigk D, Feuerhake F, Lehmann U, Schlegelberger B, Kreipe HH, Steinemann D.

Oncotarget. 2016 Dec 13;7(50):82733-82740. doi: 10.18632/oncotarget.12421.

46.

Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.

Kampers J, Orjuela-Grimm M, Schober T, Schulz TF, Stiefel M, Klein C, Körholz D, Mauz-Körholz C, Kreipe H, Beier R, Maecker-Kolhoff B.

Leuk Lymphoma. 2017 Mar;58(3):633-638. doi: 10.1080/10428194.2016.1205742. Epub 2016 Aug 11.

PMID:
27685149
47.

Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression.

Nitz U, Gluz O, Huober J, Kreipe HH, Kates RE, Hartmann A, Erber R, Moustafa Z, Scholz M, Lisboa B, Mohrmann S, Möbus V, Augustin D, Hoffmann G, Weiss E, Böhmer S, Kreienberg R, Du Bois A, Sattler D, Thomssen C, Kiechle M, Jänicke F, Wallwiener D, Harbeck N, Kuhn W.

Ann Oncol. 2017 Nov 1;28(11):2899. doi: 10.1093/annonc/mdw349. No abstract available.

PMID:
27634692
48.

[HER2 testing in gastric cancer - results of a German expert meeting].

Lordick F, Al-Batran SE, Hofheinz RD, Lorenzen S, Thuss-Patience P, Baretton GB, Dietel M, Gaiser T, Kirchner T, Kreipe HH, Quaas A, Röcken C, Rüschoff J, Tannapfel A.

Z Gastroenterol. 2016 Aug;54(8):791-6. doi: 10.1055/s-0042-110794. Epub 2016 Aug 16. Review. German.

PMID:
27529529
49.

[Necrotizing funisitis : Histopathological indicator of occult congenital syphilis].

Hussein K, Peter C, Sedlacek L, Kaisenberg CV, Kreipe HH.

Pathologe. 2017 Jul;38(4):312-316. doi: 10.1007/s00292-016-0177-5. German.

PMID:
27411696
50.

RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells.

Höckendorf U, Yabal M, Herold T, Munkhbaatar E, Rott S, Jilg S, Kauschinger J, Magnani G, Reisinger F, Heuser M, Kreipe H, Sotlar K, Engleitner T, Rad R, Weichert W, Peschel C, Ruland J, Heikenwalder M, Spiekermann K, Slotta-Huspenina J, Groß O, Jost PJ.

Cancer Cell. 2016 Jul 11;30(1):75-91. doi: 10.1016/j.ccell.2016.06.002.

Supplemental Content

Loading ...
Support Center